141 related articles for article (PubMed ID: 8381382)
1. Analysis of hepatitis C virus RNA prevalence and surrogate markers of infection among seropositive voluntary blood donors.
Romeo JM; Ulrich PP; Busch MP; Vyas GN
Hepatology; 1993 Feb; 17(2):188-95. PubMed ID: 8381382
[TBL] [Abstract][Full Text] [Related]
2. Detection of serum hepatitis C virus RNA in HCV antibody-seropositive volunteer blood donors.
McGuinness PH; Bishop GA; Lien A; Wiley B; Parsons C; McCaughan GW
Hepatology; 1993 Sep; 18(3):485-90. PubMed ID: 7689526
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C virus infection in volunteer blood donors in Taiwan. Evaluation by hepatitis C antibody assays and the polymerase chain reaction.
Wang JT; Wang TH; Sheu JC; Tsai SJ; Hsieh YS; Lin DT; Wang CY; Chen DS
Arch Pathol Lab Med; 1993 Feb; 117(2):152-6. PubMed ID: 8381269
[TBL] [Abstract][Full Text] [Related]
4. Prevalence, severity, and risk factors of liver disease in blood donors positive in a second-generation anti-hepatitis C virus screening test.
Serfaty L; Nousbaum JB; Elghouzzi MH; Giral P; Legendre C; Poupon R
Hepatology; 1995 Mar; 21(3):725-9. PubMed ID: 7875670
[TBL] [Abstract][Full Text] [Related]
5. Analysis of ELISA hepatitis C virus-positive blood donors population by polymerase chain reaction and recombinant immunoblot assay (RIBA). Comparison of second and third generation RIBA.
Chicheportiche C; Cantaloube JF; Biagini P; Aumont P; Donnadieu F; Escher J; Larabi F; Zepitelli JP
Acta Virol; 1993; 37(2-3):123-31. PubMed ID: 7692714
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C in HIV-infected patients with and without AIDS: prevalence and relationship to patient survival.
Wright TL; Hollander H; Pu X; Held MJ; Lipson P; Quan S; Polito A; Thaler MM; Bacchetti P; Scharschmidt BF
Hepatology; 1994 Nov; 20(5):1152-5. PubMed ID: 7927246
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of hepatitis C virus antibodies and genotypes in asymptomatic, first-time blood donors in Namibia.
Vardas E; Sitas F; Seidel K; Casteling A; Sim J
Bull World Health Organ; 1999; 77(12):965-72. PubMed ID: 10680243
[TBL] [Abstract][Full Text] [Related]
8. Quantitative antibody responses to structural (Core) and nonstructural (NS3, NS4, and NS5) hepatitis C virus proteins among seroconverting injecting drug users: impact of epitope variation and relationship to detection of HCV RNA in blood.
Beld M; Penning M; van Putten M; Lukashov V; van den Hoek A; McMorrow M; Goudsmit J
Hepatology; 1999 Apr; 29(4):1288-98. PubMed ID: 10094977
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and outcome of hepatitis C infection among heart transplant recipients.
Zein NN; McGreger CG; Wendt NK; Schwab K; Mitchell PS; Persing DH; Rakela J
J Heart Lung Transplant; 1995; 14(5):865-9. PubMed ID: 8800721
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and screening costs of hepatitis C virus among Ugandan blood donors.
Hladik W; Kataaha P; Mermin J; Purdy M; Otekat G; Lackritz E; Alter MJ; Downing R
Trop Med Int Health; 2006 Jun; 11(6):951-4. PubMed ID: 16772018
[TBL] [Abstract][Full Text] [Related]
11. [Seroprevalence of hepatitis C antibodies among blood donors. Study of second generation ELISA and RIBA tests and surrogate markers].
Aymard JP; Botte C; Contal P; Janot C; Streiff F
Pathol Biol (Paris); 1993 Feb; 41(2):149-53. PubMed ID: 8327265
[TBL] [Abstract][Full Text] [Related]
12. Recurrent and new hepatitis C virus infection after liver transplantation.
Everhart JE; Wei Y; Eng H; Charlton MR; Persing DH; Wiesner RH; Germer JJ; Lake JR; Zetterman RK; Hoofnagle JH
Hepatology; 1999 Apr; 29(4):1220-6. PubMed ID: 10094968
[TBL] [Abstract][Full Text] [Related]
13. Neopterin levels during the early phase of human immunodeficiency virus, hepatitis C virus, or hepatitis B virus infection.
Nübling CM; Chudy M; Volkers P; Löwer J
Transfusion; 2006 Nov; 46(11):1886-91. PubMed ID: 17076842
[TBL] [Abstract][Full Text] [Related]
14. Correlates of hepatitis C virus (HCV) RNA negativity among HCV-seropositive blood donors.
Busch MP; Glynn SA; Stramer SL; Orland J; Murphy EL; Wright DJ; Kleinman S;
Transfusion; 2006 Mar; 46(3):469-75. PubMed ID: 16533292
[TBL] [Abstract][Full Text] [Related]
15. Reliability of hepatitis C virus core antigen assay for detection of viremia in HCV genotypes 1, 2, 3, and 4 infected blood donors: a collaborative study between Japan, Egypt, and Uzbekistan.
Agha S; Tanaka Y; Saudy N; Kurbanov F; Abo-Zeid M; El-Malky M; Khalaf M; Ohta N; Yoshizawa H; Mizokami M
J Med Virol; 2004 Jun; 73(2):216-22. PubMed ID: 15122795
[TBL] [Abstract][Full Text] [Related]
16. One-step RNA polymerase chain reaction for detection of hepatitis C virus RNA.
Hu KQ; Yu CH; Vierling JM
Hepatology; 1993 Aug; 18(2):270-4. PubMed ID: 7687979
[TBL] [Abstract][Full Text] [Related]
17. A pilot study for screening blood donors in Taiwan by nucleic acid amplification technology: detecting occult hepatitis B virus infections and closing the serologic window period for hepatitis C virus.
Li L; Chen PJ; Chen MH; Chak KF; Lin KS; Tsai SJ
Transfusion; 2008 Jun; 48(6):1198-206. PubMed ID: 18422856
[TBL] [Abstract][Full Text] [Related]
18. [Prevalence of hepatitis C virus infection in Niger: comparative evaluation of second generation ELISA screening tests and tests of confirmation].
De Groof D; Michielsen P; Hassane A; Leyssens N; Ramon A; Pelckmans P
Gastroenterol Clin Biol; 1996; 20(3):320-2. PubMed ID: 8763077
[No Abstract] [Full Text] [Related]
19. Hepatitis C viral RNA amplification by the polymerase chain reaction allows detection of false positive HCV ELISAs among patients with non-A, non-B hepatitis.
Rodríguez-Medina JR; Carrasquillo EA; Sarriera JE; Medina R; Oharriz JJ; Rubio CE
P R Health Sci J; 1993 Apr; 12(1):35-8. PubMed ID: 8390064
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis C and B virus infections in hepatocellular carcinoma. Analysis of direct detection of viral genome in paraffin embedded tissues.
Edamoto Y; Tani M; Kurata T; Abe K
Cancer; 1996 May; 77(9):1787-91. PubMed ID: 8646675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
